한국재래산양 신생자의 위장관에서 chromogranin A 면역반응세포에 대한 분포 및 출현빈도에 관한 연구

이형식,구세광,이재현 慶山大學校 基礎科學硏究所 1999 基礎科學 Vol.3 No.2

한국재래산양 신생자의 위장관에서 chromogranin(Cg) A 면역반응세포의 각 부위별 출현 분포와 빈도를 면역조직화학적으로 관찰한 결과 Cg A 면역반응세포는 위장관전 부위에서 관찰되었다. 부위별 분포는 유문부(148.0/1㎟)에서 가장 높은 빈도로 출현하였고, 직장(135.0/1㎟), 위저부(106.0/1㎟), 결장(82.0/1㎟), 십이지장(67.0/1㎟), 공장(62.0/1㎟) 및 회장(33.0/1㎟)의 순으로 관찰되었다. 이들 면역반응세포들은 주로 위저부, 유문부, 십이지장, 회장 및 결장부위에서는 점막샘에 다수, 점막 상피에 소수 관찰되었으며, 공장과 결장에서는 점막 전체에 산재되어 관찰있었다. The regional distribution and relative frequency of chromogranin(Cg) A-immunoreactive cells in gastrointestinal tract of the neonate of the Korean native goat were studied with immunohistochemical methods. Cg A-immunoreactive cells were detected throughout the gastrointestinal tract and they were situated to the mucosal gland and mucosal epithelium, and these cells were most predominant in the pylorus(148.0/1㎟), rectum(135.0/1㎟), fundus(106.0/1㎟), colon(82.0/1㎟), duodenum(67.0/1㎟), jejunum(62.0/1㎟), and ileum(33.0/1㎟) were followed in that order.

비뇨기과 입원환자에서 진통이 미치는 Nabumetone(Unimetone^(�))의 임상적 효과

이홍우,김세웅,이광돈,조용현,윤문수 최신의학사 1994 最新醫學 Vol.37 No.6

싸이클론 건식공정으로 생산된 재생 잔골재가 콘크리트의 기초특성에 미치는 영향

이문환,이세현 대한건축학회 2005 大韓建築學會論文集 : 構造系 Vol.21 No.2

This study is intended for how to utilize the recycled fine aggregate which is produced by concrete wastes. It analyses the quality of the fine aggregate which is reproduced through a dry production process with cyclone, and comprehends the characteristics of mortar using the recycled fine aggregate to review whether it can be put to practical use for concrete. In: the experiment, recycled fine aggregate is substitute for natural fine aggregate the rate of 0, 25, 50, 75 and 100% each. The results of the study are as follows. 1) The air content is increased irregularly according to the substitutive ratio of recycled fine aggregate. 2) The slump and loss of slump with time since mixing are decreased irregularly according to the substitutive ratio of recycled fine aggregate. 3) The compressive strength of concrete using the wet recycled fine aggregate tends to be reduced with the increase of the mixing ratio of recycled fine aggregate, but the compressive strength of 25% substitution ratio is increased. Based on the above results, it is concluded that the recycled fine aggregate through the wet production process can be used as fine aggregate on condition that the substitution ration is under 25%.

생후 1개월령 한국재래산양의 위장관에서 chromogranin A 면역반응세포에 대한 분포 및 출현빈도에 관한 연구

이형식,구세광,이재현 慶山大學校 基礎科學硏究所 2000 基礎科學 Vol.4 No.1

생후 1 개월령의 한국재래산양 위장관에서 chromogranin A 면역반응세포의 각 부위별(위저부, 유문부, 십이지장, 공장, 회장, 결장 및 직장의 7부위) 분포와 출현빈도를 면역조직화학적 방법으로 관찰한 결과, chromogranin A 면역반응세포는 위장관 전부위에서 관찰되었다. 위장관 부위별 출현빈도는 위저부(156.0/1㎟)에서 가장 높은 출현빈도를 나타내었고, 직장(93.0/1㎟), 유문부(84.0/1㎟), 결장(79.0/1㎟), 십이지장(71.0/1㎟), 회장(55.0/1㎟) 및 공장(49.0/1㎟)의 순으로 관찰되었다. 이들 chromogranin A 면역반응세포들은 주로 위저부, 유문부, 십이지장, 회장 및 결장부위에서는 점막샘에 다수, 점막 상피에 소수 관찰되었으며, 공장과 결장에서는 점막 전체에 산재되어 관찰되었다. The regional distribution and relative frequency of chromogranin A-immunoreactive cells in the gastrointestinal tract of the Korean native goat at 1-month-old were studied with immunohistochemical methods. The digestive tract was divided into seven portions, fundus, pylorus, duodenum, jejunum, ileum, colon and rectum. Chromogranin A-immunoreactive cells were detected throughout the whole gastointestinal tract and they were situated to the mucosal glands, which were located in the basal parts of digestive tract, with round, oval and/or spindle shape and surface epithelium with spindle shape. These cells were most predominant in fundus and the relative frequencies of the other portions were observed to be in the following order: rectum > pylorus > colon > duodenum > ileum > jejunum.

접착제와 와동형성의 차이에 따른 5급 복합레진 수복의 전향적 임상연구

이경욱,정세준,한영철,손호현,엄정문,오명환,조병훈 大韓齒科保存學會 2006 Restorative Dentistry & Endodontics Vol.31 No.4

본 연구의 목적은 복합레진을 이용한 비우식성 치경부 5급 병소 수복에 있어서, 3가지 다른 접착제를, 유지구를 부여한 치아와 부여하지 않은 치아에 적용하였을 때의 임상적인 효능의 차이를 비교하기 위함이다. 총 150개의 치아를 각각 25개씩 6개의 군으로 나누었다. A군 Scotchbond Multi-Purpose (SBMP, 3M ESPE, St, Paul, MN, USA, 4세대 접착제)를 사용하고 유지구를 부여하지 않음. B군: SBMP를 사용하고 유지구를 부여. C군: BC Plus (Vericom Co., Anyang, Gyeonggido, Korea, 5세대 접착제)를 사용하고 유지구를 부여하지 않음. D군: BC Plus를 사용하고 유지구를 부여. E군: Adper Prompt (3M ESPE, Seefeld, Germany, 6세대 접착제)를 사용하고 유지구를 부여하지 않음. F군: Adper Prompt를 사용하고 유지구를 부여. 모든 치아는 복합레진인 Denfil(Vericom Co., Anyang. Gyonggido. Korea)을 이용하여 충전하였다. 수복 직후와, 수복 6개월 후에 modified USPHS (United States Public Health Service) criteria에 따라 수복물을 임상적으로 평가하였다. 추가적으로 임상사진을 촬영하였으며, 에폭시 레진을 이용하여 복제한 후 주사전자현미경을 이용하여 이를 관찰하였다. 6개월 후 관찰 결과. alpha rating의 수가 각 실험군마다 동일하지는 않았지만, 통계적으로는 3가지의 접착제간에 유의할만한 차이는 없었고, 기계적인 유지구를 부여한 군과 부여하지 않은 군 간에도 유의할만한 차이는 없었다 (p > 0.05). 그러나 6개월의 관찰 기간은 일반적으로 기대되는 레진의 수명보다 짧기 때문에, 각 실험군 간의 차이를 알아보기 위해서는 추후 더 오랜 기간의 관찰이 요구된다. The purpose of this study is to evaluate prospectively the effect of different bonding systems and retention grooves on the clinical performance of resin restorations in non-carious cervical lesions (NCCLs). Thirty nine healthy adults who had at least 2 NCCLs in their promolar areas were included in this study. One hundred and fifty teeth were equally assigned to six groups; (A) Scotchbond Multi-Purpose (SBMP, 3M ESPE, St, Paul, MN, USA, 4th generation bonding system) without retention grooves; (B) SBMP with retention grooves: (C) BC Plus (Vericom Co., Anyang, Gyeonggido, Korea, 5th generation bonding system) without retention grooves; (D) BC Plus with retention grooves; (E) Adper Prompt (3M ESPE, Seefeld, Germany, 6th generation bonding system) without retention grooves: (F) Adper Prompt with retention grooves. All cavities were filled with a hybrid composite resin, Denfil (Vericom Co., Anyang, Gyeonggido, korea) by one operator. Restorations were evaluated at baseline and at 6-month recall, according to the modified USPHS (United states Public Health Service) criteria, Additionally, clinical photographs were taken and epoxy resin replicas were made for SEM evaluation. At 6-month recall, there were some differences in the number of alpha ratings among the experimental groups. But, despite the differences in the number of alpah ratings, there was no significant difference among the 3 adhesive systems (p > 0.05). There was also no significant difference between the groups with or without mechanical retention (p > 0.05). Follow-ups for longer periods than 6 months are needed to verify the clinical performance of different bonding systems and retention grooves. 〔J Kor Acad Cons Dent 31(4):300-311, 2006〕

한국재래산양 태자의 위장관에서 Serotonin 면역반응세포의 분포 및 출현빈도에 관한 연구

이형식,구세광,이재현 慶山大學校 基礎科學硏究所 1998 基礎科學 Vol.2 No.2

임신 180일령의 한국재래산양 태자에서 위장관 각 부위에 걸쳐 serotonin 면역반응 세포의 분포와 출현빈도를 면역조직화학적으로 관찰하였던 바, serotonin 면역반응세포는 위장관 전 부위에서 관찰되었다. 부위별 분포는 유문부(74.8/1㎟)에서 가장 높은 빈도를 나타내었으며, 직장(55.6/1㎟), 공장(27.8/1㎟), 십이지장(27.5/1㎟), 결장(24.0/1㎟) 및 위저부(22.2/1㎟)의 순으로 관찰되었다. 이들 면역반응세포들은 위장관 전 부위에서 원형, 타원형 및 방추형의 형태로 점막샘 부위에서 관찰되었으며, 소수의 면역반응세포들은 점막상피에서도 관찰되었다. The regional distribution and relative frequency of serotonin-immunoreactive cells in the gastrointestinal tract of the fetus(180 days of gestation) of the Korean native goat were studied with immunohistochemical(ABC) methods. Serotonin-immunoreactive cells were detected throughout the gastrointestinal tract and these cells were situated to mucosal glands and epithelia. Theses cells were most predominant in the pylorus(74.8/1㎟), and rectum(55.6/1㎟), jejunum(27.8/1㎟), duodenum(27.5/1㎟), colon(24.0/1㎟), and fundus(22.2/1㎟) were followed in that order. The immunoreactive cells in the stomach regions were round or spherical, however these cells in the intestine were spherical to elongated spindle in shape.

인공방광대치술을 받은 환자에서의 대사 산증 발생

김새인,이동현,김광현,류동열,김승정,강덕희,최규복,이신아 이화여자대학교 의과학연구소 2015 EMJ (Ewha medical journal) Vol.38 No.3

Objectives: Metabolic acidosis frequently develops in patients after neobladder reconstruction. However, the incidence of metabolic acidosis in patients with neobladder and the factors associated with the development of metabolic acidosis have not been well elucidated. We aimed to investigate the incidence and the potential predictors for the development of metabolic acidosis after neobladder reconstruction with intestinal segment. Methods: We included patients who underwent neobladder reconstruction using intestinal segment at Ewha Womans University Mokdong Hospital between January 1, 2005 and December 31, 2014. A subgroup of patients according to the time of metabolic acidosis occurrence was further analyzed in order to characterize predictors for metabolic acidosis. Results: Metabolic acidosis was encountered in 79.4% of patients with neobladder during follow up period. When patients were divided into 2 groups according to anion gap (AG), total CO2 (18.9±2.1 mEq/L vs. 20.0±1.3 mEq/L, P=0.001) and chloride (106.6±4.9 mE/L vs. 109.4±3.6 mEq/L, P<0.001) were significant different between groups with AG>12 and AG≤12. Furthermore, when patients were divided into 3 groups; patients with metabolic acidosis at postoperative day (POD) 1; from POD 2 to 14 days; after 14 days, there was significant difference among those subgroups. Conclusion: Our study showed the rate of metabolic acidosis in patients underwent neobladder reconstruction and the difference between patients with metabolic acidosis and those without metabolic acidosis for the first time in Korea. In the future, well designed prospective study will be needed to prevent metabolic acidosis after neobladder reconstruction.

급성 단순하부요로감염증 치료에서 노르플록사신과 루플록사신의 임상효과 및 안전성

김세웅,이지열,이승주,조용현,윤문수 대한화학요법학회 2000 대한화학요법학회지 Vol.18 No.1

목적 : 루플록사신은 긴 반감기와 넓은 항균력을 가진 퀴놀론계 항생물질이다. 급성 단순하부요로감염 치료에 있어서의 루플록사신의 효과와 안전성을 평가하기 위하여 기존의 퀴놀론계 항생물질인 노르플록사신과 비교임상시험을 실시하였다. 방법 : 본 임상시험은 전향적, 무작위 방법으로 진행하였으며 1997년 8월부터 1999년 3월까지 가톨릭대학교 의과대학 부속 성모병원 비뇨기과에 내원한 급성 단순하부요로감염 환자 72명을 대상으로 하였다. 연속적 무작위 배정방법을 통하여 루플록사신군 36명과 노르플록사신군 36명이 루플록사신 400㎎을 단회 경구투여 받거나 노르플록사신 400㎎을 12시간 간격으로 3일간 6회 경구투여 받았다. 임상효과, 미생물학적 평가 및 부작용을 비교 관찰하였다. 결과 : 총 64명의 환자가 시험을 완료하여 평가가 가능하였고, 이 중 루플록사신군은 32명이었고, 노르플록사신군은 32명이었다. 증상의 치료 및 개선을 임상적 유효성이 있는 경우로 하였을 때, 루플록사신투여군은 32례중 32예(100%)에서, 노르플록사신투여군은 32례 중 31례(96.9%)에서 만족할 만한 결과를 얻었다. 미생물학적 평가에서 루플록사신투여군은 32례 중 29례(90.6%)에서, 노르플록사신투여군은 32례 중 28례(87.5%)에서 미생물학적 소실을 보였다. 미생물학적 재발은 루플록사신군과 노르플록사신군에서 각각 1례(3.1%)과 2례(6.3%)가 나타났고, 재감염은 각각 2례(6.3%)와 1례(3.1%)가 나타났다. 임상효과와 미생물학적 평가에서는 두 약제간의 통계학적 차이는 없었다. 약물역동학적 검사상 루플록사신은 노르플록사신에 비해 높은 MIC를 갖고 있지만 긴 반감기를 통해 소변내에서 높은 농도와 요 살균력을 유지함을 알 수 있었다. 부작용은 루플록사신투여군 34례 중 5례(14/7%)에서, 노르플록사신투여군 35례 중 1례(2.9%)에서 나타났으며, 대부분의 소화기계통의 이상반응 이었으며, 모두 경증으로 24시간 이내에 소실되었다. 루플록사신투여군 중 2례에서는 경증의 중추신경계의 이상반응이 관찰되었다. 결론 : 결론적으로 루플록사신은 급성 단순하부요로감염에 대하여 1회 투여만으로도 노르플록사신의 3일 투여법과 동등한 효과를 나타내는 유용한 약제라고 생각된다. Background : Rufloxacin is a broad-spectrum quinolone that exhibits a prolonged elimination half-life. The purpose of this study is to evaluate the efficacy and safety of a single dose of rufloxacin, campared with those of a norfloxacin standard treatment. Methods : This was a open. randomized. parallel-group, phase 11 clinical trial. A total of 72 women with acute lower urinary tract infections were included and randomly assigned to one of the treatment regimens: rufloxacin 400㎎ single dose, or norfloxacin 400㎎ b.i.d. for 3 days. Clinical and bacteriological assessments were performed twice at the third day and the seventh or tenth day after inclusion. Results : A total of 64 patients(32 and 32 patients in the rufloxacin and norfloxacin groups, respectively) were considered clinically and bacteriologically evaluable. Overall, a clinical response(recovery and improvement) was observed in 32 (100%) of 32 patients treated with rufloxacin and in 31 (96.95) of 32 patients with norfloxacin. The corresponding eradication rates of the primary pathogens were 90.6%(29/32) and 87.5%(28/32), respectively. The microbiological relapses between the seventh and tenth day were recorded in 1 patient(3.1%) and 2 patients(6.3%) in the rufloxacin and norfloxacin groups, respectively. The superinfections occurred in 2(6.3%) and 1(3.1%) patients, respectively. No statistically significant differences in the clinical or bacteriological outcome were observed between the treatment groups. The pharmacodynamic evaluation showed similar median urine bactericidal titers(UBT) for both treatment groups against initial isolates, despite a higher MIC of rufloxacin than that of norfloxacin. Five patients (14.7%) in the rufloxacin group and 2 patients (5.7%) in the norfloxacin group reported 9 and 4 adverse events, respectively, almost all of them being mild and lasting <24 h. Overall, gastrointestinal reactions were the most frequent adverse events reported. However, 2 patients treated with rufloxacin reported 3 central nervous system adverse events. Conclusion : This study suggests that single dose of rufloxacin treatment is effective and well tolerated as norfloxacin 3-day standard treatment in acute uncomplicated lower urinary tract infections.

요로감염증 환자의 치료에서 메로페넴(Meropenem)과 이미페넴/실라스타틴(Imipenem/Cilastatin)의 임상효과 및 안정성

김세웅,이승주,이지열,조용현,신완식,윤문수 대한화학요법학회 1999 대한화학요법학회지 Vol.17 No.1

목적 :메로페넴은 실라스타틴을 복합투여하지 않아도 되는 새로운 계열의 카바페넴계 항생물질이다. 요로감염 치료에 있어서의 메로페넴의 효과와 안전성을 평가하기 위하여 기존의 카바페넴계 항생물질인 이미페넴/실라스타틴과 동시에 비교임상실험을 실시하였다. 방법 : 본 임상시험은 전향적, 무작위 방법을 통하여 시행하였다. 1996년 10월부터 1998년 2월까지 가톨릭대학교 의과대학 부속 성모병원 및 울산대학교 외과대학 부속 중앙병원 비뇨기과에 입원한 신우신염과 복잡성방광염 환자 115명을 대상으로 하였고, 연속적 무작위 배정방법을 통하여 메로페spa군 58명과 이미페넴/실라스타틴군 57명으로 분류하였다. 두가지 약제는 모두 0.5 g을 12시간 간격으로 정맥주사 하였고, 평균 투약기간은 4일 (3-8일) 이었다. 임상효과, 세균학적 평가 및 부작용을 비교 관찰하였다. 결과 : 총 67명의 환자가 시험을 완료하여 평가가 가능하였고, 이 중 메로페넴군은 34명이었고, 이미페넴/실라스타틴군은 33명이었다. 증상의 치료 및 개선을 임상적 유효성이 있는 경우로 하였을 때, 메로페넴투여군은 34례중 32례 (94.1%)에서, 이미페넴/실라스타틴투여군은 33례중 29례 (87.9%)에서 유효율을 보였다. 세균학적 평가에서 메로페넴 투여군은 34례중 32례 (94.1%)에서, 이미페spa/실라스타틴투여군은 33례중 29례 (87.9%)에서 세균학적 소실율을 보였다. 세균학적 재발 은 각각 4명과 7명이 나타났고, 재감염은 메로페넴군은 나타나지 않았지만, 이미페넴/실라스타틴군은 2명이 나타났다. 임상효과와 세균학적 평가에서는 두 약제간의 통계학적 차이는 없었다. 부작용은 메로페spa투여군 56례중 1례 (1.8%)에서, 이미페넴/실라스타틴투여군 53례중 1례 (1.9%)에서 나타났으며, 임상검사치 이상은 메로페넴투여군 45례중 10례 (22.2%)에서, 이미페넴 실라스타틴투여군 44례중 8례 (18.2%)에서 나타났으나 전체적으로 특별히 문제가 된 증례는 없었다. 결론 :결론적으로 메로페spa은 신우신염 및 복잡성방광염과 같은 요로감염에 대하여 이미페넴/실라스타틴과 동등한 효과를 나타내는 유용한 약제라고 생각된다. Background : Metopenem is the first of a new class carbapenems which may be administered without cilastatin. The clinical study was carried out to assess efficacy and safety of metopenem in the treatment of urinary tract infections, in comparison to imipenem/cilastatin. Methods : This was a controlled, two-center, prospective, randomized study with two parallel groups. From October 1996 until February 1998, a total of 115 consecutive patients with urinary tract infections, such as pyeolonephritis and complicated cystitis, were randomly allocated into two groups, 58 in the meropenem group and 57 in the imipenem/cilastatin group. Both drugs were administered intravenously, at a dose of 0.5 g every 12 hours. The mean duration of therapy was 4 days (3-8 days) for both treatment. Clinical and bacteriological reponses were assessed at the begining of treatment, during treatment, at the end of treatment, and follow-up (1-2 weeks). Results : A total of 67 patients, 34 of meropenem and 33 of imipenem/cilastatin, were evaluable for response. Overall, a positive clinical response (recovery and improvement) was observed in 32 (94.1%) of 34 patients treated with meropenem and in 29 (87.9%) of 33 patients with imipenem/cilastin and the corresponding eradication rates of the primary pathogens were 32 (94.1%) of 34 patients and 29 (87.9%) of 33 patients, respectively. The microbiological relapse after the treatment completion was recorded in 4 patients treated with meropenem and 7 patients given imipenem/cilastath and superinfections occurred in none and 2 patients, respectively. No statistically significant differences in the clinical or bacteriological outcome were observed between the treatment groups. Both drugs were well tolerated with adverse events considered to be related to therapy being recorded for 1 (1.8%) of 56 patients treated with meropenem and 1 (1.9%) of 53 of those who had been given imipenenjcilastatin. Conclusion : Empirial monotherapy with meropenem was therefore as effective and as well tolerated as that with imipenem/cilastatin for the treatment of urinary tract infections.

직연신 방사과정에서의 폴리프로필렌 구조해석 : 분자량 및 권취속도에 따른 영향 Effect of Molecular Weight and Take-up Velocity

신현세,이태균 단국대학교 1998 論文集 Vol.33 No.-

Abstrack : The development of the structure of polypropylene fibers during the direct drawing melt spinning process was analyzed by comparing fibers which have gone through the whole direct drawing melt spinning process and fibers in which the drawing step was omitted. The relative contribution of the drawing step was evaluated so that the information on the stages of development of the structure can be utilized as the foundation for future research on functional or high performance fibers. Four different molecular weights and take­up speeds were utilized to study the effect of these variables on the development of the structure. The samples taken up omitting the drawing step were designated as undrawn fibers and the fibers in which the drawing was carried out as drawn fibers. When the properties of the drawn fibers were taken as reference and the degree of structure formation in the undrawn fibers described by the percentage therof, 99, 85 and 95% of the density crystallinity and crystalline orientation had already developed prior to the drawing step. In the other hand the overall orientation was found to be more dependent on the drawing process, with about 64-73% of the orientation being developed in the drawing step and 26.8-36.1% being developed prior to the drawing step. The amorphous orientation of the undrawn fibers exhibited a negative value suggesting that the rotation of lamella to the final structure occurs in the drawing step. The highest tenacity obtained in this experiment was 4.5g/den and the highest modulus 25.4g/den when PP of Mn=230,000 was spun at 800m/min.